For most of the last century, mitochondria were taught as the cell’s power plants — important, but essentially plumbing. MOTS-c is part of a discovery that turns that picture on its head: the mitochondria don’t just make energy, they send messages. And MOTS-c is one of the most intriguing messages they send.
A peptide written inside the mitochondria
MOTS-c is a 16-amino-acid peptide, and its most remarkable feature is where it comes from. It is encoded not in the nuclear genome but within the mitochondrial 12S ribosomal RNA gene — a tiny message written into the DNA of the cell’s power plants themselves. When Changhan Lee and colleagues characterized it in a 2015 Cell Metabolism paper, they described something genuinely new: a signal that originates in the mitochondria and travels outward to help coordinate the metabolism of the whole body.
Mechanistically, MOTS-c converges on AMPK — the master sensor that tells a cell when energy is running low and switches on fuel-burning, stress-adapting programs. In other words, it appears to be part of how a cell reads its own energetic state and responds.
What the research has revealed
Two findings make MOTS-c especially compelling. In that first study, giving MOTS-c to mice improved insulin sensitivity and guarded against diet-induced weight gain, and it activated some of the same metabolic pathways associated with exercise. Then in 2021, a Nature Communications study added a beautiful twist: MOTS-c is induced by exercise, it declines with age, and administering it improved physical performance in young, middle-aged, and older mice alike.
Put those together and you have an elegant idea worth getting excited about: a mitochondrial peptide that rises when we move, fades as we age, and — in animals — helps restore some of the metabolic vigor of youth. Few molecules connect exercise, mitochondria, metabolism, and aging quite so directly.
What we are still learning
The frontier here is human biology, and it is genuinely open. What we already know is genuinely encouraging: MOTS-c is an authentic human physiological signal — detectable in people, responsive to exercise, and shifting with age — which is exactly what makes it worth pursuing. What researchers are still working to establish is the next question — whether supplementing MOTS-c reproduces the striking metabolic benefits seen in mice. A convincing human interventional trial would need clearly defined dosing, sufficient duration, an appropriate control group, and pre-specified endpoints such as insulin sensitivity, exercise capacity, body composition, or another clinically meaningful metabolic measure — the natural next step for turning a compelling signal into knowledge. That work is early, and it is exactly the kind of question that makes this field thrilling to follow: a clear mechanism, a strong animal signal, and a human story still being written.
Why it matters
MOTS-c is a window into a larger shift in how we understand our own cells — from static energy factories to dynamic communicators shaping how we age and adapt. Whether or not it becomes a therapy, it has already expanded the map of what mitochondria do. The most useful way to follow it is with curiosity and precision at once: to appreciate how much the biology has revealed, and to watch, eagerly, as the human research fills in what comes next.